Anantco Enterprises

Mumbai, India
Offers pharmaceutical imports, exports, manufacturing, and performance chemical services.

About Anantco Enterprises

Anantco Enterprises is a company based in Mumbai (India). It operates as a B2B and Manufacturing. The company has 82 employees. Anantco Enterprises offers products and services including Pharmaceutical Imports, Medical Devices, Performance Chemicals, and Veterinary Feed Pre-Mixes. Anantco Enterprises operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.

Key Metrics
  • Annual Revenue
    ₹39.54 Cr

    FY 2024 · +5% YoY

  • Net Loss
    -₹82.5 Lakh

    FY 2024 · -2% margin

  • EBITDA
    ₹65.2 Lakh

    FY 2024 · 2% margin

  • Employee Count
    82

Products & Services of Anantco Enterprises

Anantco Enterprises offers a comprehensive portfolio of products and services, including Pharmaceutical Imports, Medical Devices, Performance Chemicals, and Veterinary Feed Pre-Mixes.

Pharmaceutical Imports
Import Services

Manages import of APIs and pharmaceutical intermediates for clients.

Medical Devices
Device Manufacturing

Handles registration and manufacturing of medical devices globally.

Performance Chemicals
Chemical Solutions

Provides fire retardant and water treatment chemicals for industries.

Veterinary Feed Pre-Mixes
Veterinary Products

Offers pre-mixes for animal feed in pharmaceutical applications.

Board of directors of Anantco Enterprises Private Limited (Anantco Enterprises)

Anantco Enterprises Private Limited is the primary company behind Anantco Enterprises. The boards of the 2 registered companies of Anantco Enterprises currently have 5 directors; the longest-serving is Anil Rajendralal Thakore, appointed in 2015. 5 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Anil Rajendralal Thakore
DIN 00840894
Director01 Jun 201511 yrs 4 moAnantco Enterprises Private Limited
Darshan Anil Thakore
DIN 00840871
Designated Partner07 Dec 20187 yrs 10 moOrigami Chemicals Llp, Anantco Enterprises Private Limited
Rahil Darshan Thakore
DIN 08924760
Designated Partner02 Mar 20215 yrs 7 moOrigami Chemicals Llp
Rhea Darshan Thakore
DIN 08924698
Designated Partner19 Jan 20224 yrs 8 moOrigami Chemicals Llp
Tejal Darshan Thakore
DIN 02661290
Designated Partner19 Jan 20224 yrs 8 moOrigami Chemicals Llp

Financials of Anantco Enterprises

Figures of Anantco Enterprises Private Limited, the primary company behind Anantco Enterprises, for FY 2024. Revenue was ₹39.54 Cr (+5% year on year). Net loss was -₹82.5 Lakh (-2% margin). EBITDA was ₹65.2 Lakh (2% margin). Revenue has grown at a compounded annual rate of -20% over three years and -3% over five years.

  • ₹39.54 CrRevenue · FY 2024 · +5% YoY
  • -₹82.5 LakhNet loss · -2% margin
  • ₹65.2 LakhEBITDA · 2% margin
  • ₹1.75 CrPaid-up capital
  • 82Employees (provident fund records)
  • -20%Revenue CAGR, 3 years
  • -3%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Anantco Enterprises Private Limited are on its company page.

Premium access

Detailed financial statements for Anantco Enterprises

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of Anantco Enterprises

Anantco Enterprises operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
lauruslabs.com2005Hyderabad, India$229.73M6,035
Pharmaceutical and biotechnology company
symbiotec.in2002Indore, India$61.01M1,822
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
provepharm.com1998Marseille, France$145.93M–
APIs and drug products are developed and valorized in pharmaceuticals.
biostar-pharm.com2002Beijing, China$135.23M–
APIs, intermediates, and biochemical reagents are developed and manufactured.
sequent.in2002Bengaluru, India––
APIs are developed and manufactured for therapeutic areas.
sterlingpharmasolutions.com2016Dudley, United Kingdom–560
Contract development, manufacturing, and analytical services for APIs are offered.
divislabs.com1990Hyderabad, India–11,845
Contract manufacturer of APIs, intermediates, and building blocks of peptides and nucleotides
snapdragonchemistry.com2014Cambridge, United States–43
Drug discovery and development service provider
nglfinechem.com1981Mumbai, India–395
CDMO specializing in multi stage organic synthesis of generic APIs and fine chemicals
Premium access

Detailed competitors of Anantco Enterprises

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Similar companies to Anantco Enterprises

10 companies that operate in the same segment as Anantco Enterprises (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Pharmaceutical products are manufactured and marketed worldwide.
1891Kenilworth, Warwickshire, United Kingdom–USD 64.93 B781
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United States–USD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United States–USD 61.16 B55,000
Traditional pharmaceutical medicines are developed for multiple health fields.
1876United States–USD 65.18 B47,000
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
1987Foster City, California, United States–USD 29.45 B17,600
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology.
1993San Francisco, California, United StatesUSD 215.5 MUSD 29.62 M225
Developer of medical devices, generic pharmaceuticals, and nutrition products
1888Libertyville, Illinois, United States–USD 44.33 B3,710
Medicines and health products are retailed through pharmacy outlets.
2006Hyderabad, Telangana, IndiaUSD 268.78 MUSD 734.57 M25,010
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Anantco Enterprises

Anantco Enterprises is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Anantco Enterprises has 82 employees.

The primary company behind Anantco Enterprises, Anantco Enterprises Private Limited, reported revenue of β‚Ή39.54 Cr for FY 2024, up 5% year on year.

Anantco assists in pharmaceutical manufacturing, imports, and exports of APIs and intermediates, while handling medical devices and performance chemicals like fire retardants. Based in Mumbai, India, with an ancillary office in China, the company supports Indian pharma firms through supplier identification, quality compliance, and regulatory procedures. It serves manufacturers by facilitating market access and providing comprehensive services including RD and documentation.

Anantco Enterprises's top competitors include Laurus Labs, Symbiotec and NGL Fine Chem.

Anantco Enterprises offers Pharmaceutical Imports, Medical Devices, Performance Chemicals, and Veterinary Feed Pre-Mixes.

Anantco Enterprises is associated with 2 legal entities: Anantco Enterprises Private Limited, Origami Chemicals Llp.

The legal entities of Anantco Enterprises currently have 5 directors, including Rhea Darshan Thakore, Rahil Darshan Thakore, Tejal Darshan Thakore and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available